SBWire

B. Braun Melsungen AG (B. Braun) is a global health care company. It markets and sells products and services catering to basic healthcare, intensive care units, anesthesia and emergency care sectors. The company also provides solutions for extracorporeal blood treatment and core surgical procedures. The company operates in four business divisions namely, Hospital Care division, which supplies the hospitals with infusion, injection solutions and disposable medical products; Aesculap division, which supplies products and services for all the core processes in surgery; Out Patient Market (OPM) division, which supplies medical products outside the hospital for chronically ill and long term care patients; and B. Braun Avitum division compiles the product and services concerning extra-corporeal blood treatment. It operates in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

Pronota NV (PNV) is a diagnostic service provider. It develops and commercializes diagnostics for early detection of life-threatening conditions and unmet medical conditions. The company provides diagnostics for heart failure, pre-eclampsia and sepsis. The company has four programs in its pipeline which includes protein diagnostic blood tests and protein biomarkers. Its products are used in the areas of heart failure, cardio-renal, pre-eclampsia and sepsis. PNV's lead heart failure marker CD146 has multiple clinical utilities. The technology platforms of the company include proteomics platform, MASStermind - low abundance protein biomarker discovery and MASSterclass - low abundance protein biomarker validation platforms. PNV is headquartered in Ghent, Flandre Orientale, Belgium.

GlobalData's new report, "Japan Duodenoscopes Market Outlook to 2020", provides key market data on the Japan Duodenoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Duodenoscopes and Flexible Non-Video (Fibre) Duodenoscopes.

GlobalData's new report, "Japan Cystoscopes Market Outlook to 2020", provides key market data on the Japan Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Video Cystoscopes (Rigid Non-Video Cystoscopes and Flexible Non-Video (Fibre) Cystoscopes).

GlobalData's new report, "South Korea Cystoscopes Market Outlook to 2020", provides key market data on the South Korea Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Video Cystoscopes (Rigid Non-Video Cystoscopes and Flexible Non-Video (Fibre) Cystoscopes).

GlobalData's new report, "Canada Laryngoscopes Market Outlook to 2020", provides key market data on the Canada Laryngoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Video Laryngoscopes (Flexible Video Laryngoscopes and Portable Video Laryngoscopes) and Non-Video Laryngoscopes (Rigid Non-Video Laryngoscopes and Flexible Non-Video (Fibre) Laryngoscopes).

Sysmex Corporation (Sysmex) is a medical device company. It undertakes research, development, manufacturing and sale of instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. Sysmex also explores wide range of opportunities in the life science field. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. Its diagnostic products address hematology, hemostasis, immunochemistry, clinical chemistry, and urinalysis fields. The company conducts research and development activities at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in 29 countries throughout the world across Japan, America, Europe, China and Asia Pacific. Its products are used by medical institutions in more than 170 countries. Sysmex is headquartered in Hyogo, Japan.

GlobalData's new report, "India Surgical Generators Market Outlook to 2020", provides key market data on the India Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators.

Baxter International Inc. (Baxter) is a diversified global healthcare company. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It manufactures intravenous (IV) solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; IV nutrition products; infusion pumps; and inhalation anesthetics. It also offers recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The company operates in two divisions: BioScience and Medical Products. It has operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, the US.

GlobalData's new report, "Brazil Endoscopy Visualization Systems Market Outlook to 2020", provides key market data on the Brazil Endoscopy Visualization Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - High-End Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy Visualization Systems.

GE Healthcare formerly GE Medical Systems is a global medical device company. It carries out the design, development, manufacture and distribution of medical systems in the field of medical imaging and information technologies, medical diagnostics, patient monitoring, drug discovery, and biopharmaceutical manufacturing technologies. The company conducts its operations in five divisions, namely, Surgery, Healthcare Systems, Life Sciences, Medical Diagnostics and Healthcare IT. GE Healthcare also provides services such as performance improvement and performance solutions services, computerized data management and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE Healthcare is a business unit of General Electric Company and is headquartered in Buckinghamshire, the UK.

GlobalData's new report, "France Capsule Endoscopy Systems Market Outlook to 2020", provides key market data on the France Capsule Endoscopy Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Capsule Endoscopes, Capsule Endoscopy Data Recorders and Capsule Endoscopy Workstations.

More children than ever before are struggling with arthritis pain and medical professionals throughout the U.S. place the blame firmly on obesity. Joints contain the natural chemical compounds of glucosamine, chondroitin and MSM to maintain joint health. Many believe that the body’s production of these compounds can be augmented with a glucosamine dietary supplement to relieve pain.

GlobalData's new report, "North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020", provides key market data on the North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

Becton, Dickinson and Company (BD) is a medical technology company. It manufactures and sells medical devices, reagents and instrument systems used by life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company provides a broad range of products such as syringes, needles, blood collection devices, IV catheters and surgical instruments. The company through BD Technologies conducts research and development activities to improve manufacturing and process methods. Its products are manufactured and sold in the US, Canada, Europe, the Middle East, Africa, Japan, Asia Pacific, and Latin America. BD is headquartered in New Jersey, the US.

Proteome Sciences Plc (Proteome Sciences) is a life sciences company. It delivers content for personalized medicine in various areas such as biomarker assays, isobaric and isotopic reagents, biomarker services and proprietary biomarkers. The company specializes in providing proteomics and peptidomics services and applications, and mass spectrometry protein analysis capability. It offers PS Biomarker Services under which it provides integrated proteomic services for the discovery, validation and measurement in clinical trials and in vitro diagnostics of biomarkers. The company develops novel biomarkers in various disease areas such as central nervous system diseases including Alzheimer's, Huntington's, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in Cobham, the UK.

GlobalData's new report, "Canada Ureteroscopes Market Outlook to 2020", provides key market data on the Canada Ureteroscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Ureteroscopes and Non-Video Ureteroscopes (Semi-Rigid Non-Video Ureteroscopes and Flexible Non-Video (Fibre) Ureteroscopes).

GlobalData's new report, "United Kingdom Surgical Generators Market Outlook to 2020", provides key market data on the United Kingdom Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators.

GlobalData's new report, "France Cystoscopes Market Outlook to 2020", provides key market data on the France Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Video Cystoscopes (Rigid Non-Video Cystoscopes and Flexible Non-Video (Fibre) Cystoscopes).

The importance of medical alert jewelry for those with chronic medical issues is undeniable and so is the significance of stylish accessorizing; keeping both these aspects in mind, My IDentity Doctor has enhanced the variety in their collection and included fashion too. They are now offering Medical ID Bracelets with Green & White Murano Glass Hearts. These jewelry not only perform the crucial function of informing medical professional about the ailment of the patient during medical emergencies, but also serve as a fashionable everyday accessory. The offered Green & White Murano Glass Hearts are ideal option for those who refrain from wearing Medical Alert Bracelets as they find them not so fashionable.

Masimo Corporation (Masimo) is a global medical technology company. It manufactures and distributes of non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. Masimo SET is the company's lead technology helps to detect life threatening events. The other technologies of Masimo include Pulse CO-Oximetry technology, which allows noninvasive and continuous monitoring of blood constituents, brain and breath and Patient SafetyNet, a remote monitoring and wireless clinician notification system. The company's key products include pulse oximeters, patient monitors, patient cables, central monitoring systems, specialty sensors, circuit boards, remote-alarm and monitoring solutions. Its products are sold directly to hospitals, emergency medical services (EMS), physician offices, veterinarians, long term care facilities, and consumers market through a network of distributors and direct sales representatives. The company operates in the US, Europe, Middle East, Asia, Latin America, Canada, and Australia. Masimo is headquartered in California, the US.

GlobalData's new report, "Spain Surgical Generators Market Outlook to 2020", provides key market data on the Spain Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators.

GlobalData's new report, "Brazil Cystoscopes Market Outlook to 2020", provides key market data on the Brazil Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Video Cystoscopes (Rigid Non-Video Cystoscopes and Flexible Non-Video (Fibre) Cystoscopes).

GlobalData's new report, North America Pyeloplasty Procedures Outlook to 2020, provides key market data on the North America Pyeloplasty Procedures.

Sequenom, Inc. (Sequenom) is a life sciences company. The company carries out the development and manufacture of DNA analysis systems and related consumables and reagent kits for fine mapping genotyping applications, biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research. The company offers molecular based, laboratory developed tests (LDTs) with a focus on prenatal diseases and conditions; as well as ophthalmological diseases and conditions; as well as provides technology and research use only tools: the MassARRAY System platform, chip and reagent consumables, software and biomarker assay panels. The company operates across the Americas, Asia and Europe. Sequenom is headquartered in California, the US.